T cell receptor (TCR) recognition of foreign peptide fragments, presented by peptide major histocompatibility complex (pMHC), governs T-cell mediated protection against pathogens and cancer. Many factors govern T-cell sensitivity, including the affinity of the TCR-pMHC interaction and the stability of pMHC on the surface of antigen presenting cells. These factors are particularly relevant for the peptide vaccination field, in which more stable pMHC interactions could enable more effective protection against disease. Here, we discuss a method for the determination of pMHC stability that we have used to investigate HIV immune escape, T-cell sensitivity to cancer antigens and mechanisms leading to autoimmunity.
Background
The ability of CD8 + T-cells to respond to foreign invaders or dysregulated self is dependent on stable pMHC class I (pMHCI) presentation at the cell surface. Structurally, MHCI molecules form a peptide binding groove formed of two parallel α helices with a floor of β sheets at the interface between the α1 and α2 domains (Latron et al., 1992) . The peptide binding groove has primary peptide binding pockets (B and F) that tightly interact with specific amino acids towards the N-and C-terminals of bound peptides. Although these pockets can accommodate a range of amino acids, they exhibit preferences for certain side chains that have been characterized using structural and biochemical approaches (Parker et al., 1992) . This information has been used to generate so called 'heteroclitic' peptides in which natural peptides that have poor MHC-anchors can be modified with amino acids that bind optimally to MHC for vaccination (Cole et al., 2010) . Moreover, pMHC stability has been linked to HIV immune escape (Bronke et al., 2013) and the selection of autoreactive T-cell clones (Yin et al., 2011) . Thus, understanding the mechanisms that control pMHC stability are important for therapeutic design and understanding complex human diseases. Here, we developed a protocol to accurately determine pMHC stability using circular dichroism spectroscopy. We have used this technique, together with structural, biophysical and cellular experiments, to provide new insight into the molecular factors that determined T-cell antigen recognition in the context of a range of human diseases (Kløverpris et 
4.
Liquid Chromatography system, with a 2 ml injection loop, and a fraction collector; we use the ÄKTA pure 25 L with a F9-R fraction collector (GE Healthcare, model: ÄKTA pure 25 L)
5.
Size exclusion chromatography column; we use a Superdex 200 Increase 10/300 GL column, bed volume 24 ml (GE Healthcare, catalog number: 28990944)
6.
Benchtop refrigerated micro-centrifuge capable of 14,000 x g (e.g., Eppendorf, model: 5418 R)
7.
Far-UV spectrophotometer with a bandwidth < 
Procedure

A.
Purification and buffer exchange of pMHC protein HLA-A2 and human β2-microglobulin (β2m) sequences were generated as described and cloned into separate pGMT7 expression plasmids (Cole et al., 2007) . Complexes of HLA-A2, β2m and peptides are refolded and purified as described (Bulek et al., 2012 , MacLachlan et al., 2017 with the essential steps summarized below. For CD analysis, proteins should be of high purity and the preparation should lack the presence of denatured or incorrectly folded protein.
In order to achieve this the proteins are purified on the day of, or the day before analysis, and stored on ice to avoid any freeze thaw cycles. 
1.
Prepare a 500 ml solution of PBS using 1 tablet per 100 ml of ultra-pure water. With the bottle top filtration device and vacuum pump, filter this solution through a cellulose nitrate 0.45 μm filter paper, with a 1.2 μm glass microfiber filter as a pre-filter, into a 500 ml Duran bottle. Prepare another 500 ml Duran bottle of ultra-pure water.
2.
Connect the gel filtration column to the ÄKTA FPLC system and wash with sterile ultra-pure water followed by equilibrating the system with PBS. Wash the 2 ml injection loop with ultra-pure water and equilibrate with PBS using a 10 ml syringe, taking special care to avoid the occurrence of any air gaps that can be transferred to the column.
3.
Using a 25 G needle transfer the protein solution, of no more than 1 ml, into the injection loop using a 1 ml syringe avoiding any air bubbles.
4.
Run the column at 0.5 ml/min and monitor elution by UV absorbance at 280 nm (Note 1). Collect 1-ml fractions (the number of fractions depends on the elution profile, but we try and take 2-4 fractions from the center of the peak) and analyse by SDS-PAGE under reducing conditions to check for purity of the pMHC sample. We use 4-12% gradient Bolt ® Bis-Tris gels, BLUeye prestained protein ladder, NuPAGE MES running buffer, and Quick Coomassie Stain.
5.
Run a SDS-PAGE. Upon SDS-PAGE, pMHC dissociates into its constituent parts. Bands of HLA-A2 and β2m run at positions corresponding to ~32 and ~12 kDa, respectively. The peptide (~1 kDa) will run out of the gel ( Figure 1 ).
6.
Combine only the purest two or three fractions and concentrate using an Amicon centrifugal filtration tube with a MWCO of 10 kDa. This provides protein of adequate purity and concentration for CD analysis.
7.
Directly before CD measurements, spin the samples at 14,000 x g for 20 min at 4 °C usually without resulting in any visible pellet.
B.
Determination of parameters
1.
Record UV spectra of the supernatant (step A7) from 360 to 230 nm in a 1-cm quartz cuvette with the buffer baseline subtracted. Within the 360 to 320 nm range, the absorbance should be essentially zero; any slope is due to light scattering indicating the presence of large aggregates.
2.
Calculate the 280 nm absorption coefficient based on the amino acid composition (Pace et al., 1995) Europe PMC Funders Author Manuscripts coefficient) can be expected. As HLA-A2 and β2-microglobulin have two and one intra-chain disulphide bonds, respectively, the cystine contribution to the absorption is included (ProtParam option: 'assuming all pairs of Cys residues form cystines').
3.
Calculate protein concentration from the measured optical density at 280 nm as:
(1)
4.
Use ProtParam to calculate the molecular mass based on the average isotopic masses of amino acids. All three sequences of the HLA-A2/ β2m/peptide complex are entered into the program input field together.
To account for the two missing peptide bonds due to the three instead of single chain complex as seen by the program, two times the molecular mass of water (2 x 18.02) is added to the resulting mass Mr.
5.
Calculate the mean residue weight (MRW) required for the normalization of the CD data from this mass by dividing through the number of peptide bonds:
where, n is the number of amino acids within the trimer.
C.
Data acquisition
1.
Based on the concentration of the stock solution determined as described above, dilute an aliquot with buffer to result in ca. 600 μl of sample with c ~0.15 mg/ml (~3 μM), and record a further absorption spectrum to give the final protein concentration (Note 2).
2.
Following the usual start-up procedure of the CD instrument (30 min flushing with N 2 followed by a further 30 min period for stabilizing the xenon arc lamp), record a spectrum of the buffer (step A1) in a clean 0.1-cm stoppered quartz cell from 260 to ~195 nm with the cell holder equilibrated to 4 °C. This spectrum is termed the baseline. We usually record spectra using a 1 nm bandwidth in 0.2 nm intervals with 3 or 4 sec measuring time per data point resulting in ca. 20 to 25 min per spectrum (Note 3).
3.
Record a further buffer baseline in the Kinetic Mode at a constant wavelength of 218 nm for 1 min in 2 sec intervals.
4.
Clean the cell with water by rinsing, followed by rinsing with absolute ethanol and dried under a stream of nitrogen. Europe PMC Funders Author Manuscripts
5.
Fill the same cell completely with the protein solution (~550 μl), closed tightly with a Teflon stopper avoiding trapping of an air bubble, and place into the CD cell holder in the same orientation as used for recording the baseline.
6.
After ~2 min to allow for temperature equilibration, record the protein spectrum using the same instrument settings as used for the baseline. Data are reliable if the photomultiplier dynode voltage is < 500 V (Note 4).
7.
For temperature denaturation, set the wavelength to 218 nm (minimum in CD spectrum). Record changes in ellipticities in 0.5 °C intervals from 4 to ~80 °C using the following parameters: data collection 12 sec/point; temperature equilibration 12 sec; temperature dead band 0.3 °C; instrument heating rate 4 °C/min. During the intervals between data collection, the sample is shielded from the light beam by a closed slit. These settings result in an average heating rate of ~36 °C/h (Note 5).
8.
At elevated temperatures the HLA-A2/β2m/peptide complexes form large, visible aggregates (precipitation) that result in sharp changes of the melting profile and an increase of the dynode voltage indicating increased scattering. At this point, the measurement can be stopped.
9.
Clean protein precipitate containing cuvettes thoroughly rinsing with water followed by filling with 70% HNO 3 in a fume hood, incubation for 2 h to overnight, rinsing with water, ethanol, and drying with a stream of N 2 .
Data analysis
1.
Import CD data files into the OriginLab software (Note 6).
2.
For spectra analysis, subtract the buffer baseline. 
with the concentration c in mg/ml and cell path length d in mm (Note 7).
3.
Subtract the mean of Θ recorded at 218 nm in the Kinetic Mode (step C3) from the thermal melt ellipticities, and normalize to [Θ] MRW 218nm according to Eq.
.
4.
Analysis of the thermal stability assumes a 2-state mechanism in which three unfolded polypeptide chains U combine to a native complex N:
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Europe PMC Funders Author Manuscripts (4) where, the equilibrium constant K is: (5) with a total chain concentration c 0 = c U +3c N and a degree of conversion to the native state F = 3 c N /c 0 (see e.g., Engel et al., 1977; Marky and Breslauer, 1987) .
The standard Gibbs free energy can be written as: (6) in which R is the gas constant (8.3145 J K -1 mol -1 ), ΔH 0 the standard enthalpy, and ΔS 0 the standard entropy. From Eqs. (5) and (6) (10) which is used for fitting with the Levenberg-Marquardt algorithm implemented in OriginLab. The essential parts of the fitting script are included as Supplement 4.
5.
As the HLA-A2/β2m/peptide complexes tend to precipitate within the transition region (step C8), we assume a common molar ellipticity 
6.
Representative data
The general procedure to analyse the stability of a trimeric pMHC complex is illustrated using HLA-A2/β2m/ILAKFLHWL as an example (Figure 2 ).This complex has been analysed in detail ) and the structure has been solved in complex with a TCR (Protein Data Bank entry 5MEN).
a.
Absorption coefficient and mean-residue-weight are calculated by putting all three sequences (Supplements 1 to 3) into the input frame of ProtParam (step B2) resulting in: 
c.
MRW is calculated according to Eq. (2) as MRW = (44,820.03 + 2 x 18.02)/(386 -3) = 117.12.
d.
A CD buffer baseline and spectra of both solutions are recorded according to steps C2 to C6 using a 0.1-cm path length cuvette. Baselines were subtracted, and the spectrum is normalised according to Eq. (3) (Figure 2B ). At 195 nm, the dynode voltage was ~500 V. This reflects the high absorbance of the chloride ion included in PBS. The spectrum shows a minimum of [Θ] MRW = -8,950 deg cm 2 dmol -1 at 218 nm.
e.
The melting curve is recorded as described in step C7 from 4 to 65 °C, the mean value of the baseline (step C3) is subtracted, and molar residue ellipticities calculated according to Eq. (3) ( Figure 2C ). Using the OriginLab script given as Supplement 4 fit the data according to Eq. (10) . Values in the 59 to 65 °C range that show a pronounced deviation from a homogenous quasi-sigmoidal curve indicating protein aggregation (open dots in Figure 2C ) were omitted from the fits. Fitting results in T m = 54.5 ± 0.1 °C and ΔH 0 = -500 ± 20 kJ/mol with a coefficient of determination r 2 = 0.988.
Notes
1.
Peak fractionation of the pMHC will occur at an elution volume of ~12 ml; it is important to keep only the purest fractions and discard any that contain protein from more than one peak.
2.
To determine thermodynamic parameters, for HLA-A2/β2m/peptide complexes we aim for a concentration of ~0.15 mg/ml as for most peptides studied so far this can be relatively easily achieved and provides for a good signal-to-noise ratio to follow CD transition curves at 218 nm. Due to the concentration dependence of T m for multi-chain proteins [Eq. (7)], it is important to settle for a narrow range to allow for comparison of data.
3.
A cuvette can be regarded as optically clean if the baseline using PBS or water runs about parallel to a spectrum recorded without a cell in the light beam ('air baseline'); minima observed in the 200 to 225 nm range usually indicate that protein from previous measurements is absorbed to the quartz surface.
4.
On instruments of other manufacturers, the dynode voltage is called HT (high tension), and the reliable voltage range can differ depending on the type of photomultiplier and electronics.
5.
The heating parameters have been tested to result in the set equilibrium temperatures by measuring with a Pt100 Resistance Temperature Detector inside a 0.1-cm cuvette.
6.
The AVIV instrument software stores data in ASCII format. Some instruments from other manufacturers use propriety formats that require exporting into ASCII for analysis via other programs.
7.
[Θ] MRW can be converted into molar absorption units Δε = ε L -ε R = [Θ] MRW / 3,298, where Δε is the absorption difference for left-and right-handed circularly polarized light.
8.
From the various MHC complexes studied in our lab, HLA-A*0101/β2m/peptide VTEHDTLLY exhibit high stability both with respect to T m (68.9 °C) and 
9.
For strict thermodynamic analysis reversibility of the transition [Eq. (4)] is a prime requirement. It has been suggested, however, that even if reversibility is limited analysis is still of value as temperature induced cooperative unfolding is usually a much faster process than the aggregation of unfolded protein (Privalov, 2009 ). To allow for comparison of data, we use the same heating parameters for all samples (see step C7). A. Protein concentration is determined by UV absorbance spectroscopy. Wavelength scans from 360 to 230 nm are recorded in a 1-cm quartz cuvette using the same sample and buffer as used in subsequent CD measurements. Concentration is calculated assuming an absorbance coefficient = 2.257 as calculated based on the amino acid composition. B. A far-UV CD spectrum was recorded in a 0.1-cm quartz cuvette at 4 °C and buffer baselines measured in the same cell using the same instrument parameters were subtracted. The signals were normalized to mean-residue-weight (MRW) ellipticities [Θ] MRW acc. Eq. 
